China International Capital Corporation's Research Reports state that despite continuous adjustments in the medical Industry, slow progress in equipment procurement, and factors like IVD and high-consumption procurement, listed medical instruments companies have experienced some performance disturbances in recent quarters. However, we have also observed that the marginal impacts of these factors are gradually weakening or improving. The specialized tracks in the medical instruments Sector are expected to benefit from product upgrades and overseas exports in 2025.